SCHEMBL1464640

SCHEMBL1464640

CCc1cc(CCC2(C3CCCC3)CC(O)=CC(=O)O2)cc(CC)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3437778 1.00
SCHEMBL1581817 0.80
SCHEMBL5880929 0.79 SMN1; SMN2 (0.33)
SCHEMBL8340435 0.78 SMN1; SMN2 (0.35)
SCHEMBL5880743 0.78 SMN1; SMN2 (0.35)
SCHEMBL5880890 0.78 OPRM1 (0.40)
SCHEMBL5880887 0.78 OPRM1 (0.40)
SCHEMBL5881112 0.78 OPRM1 (0.40)
SCHEMBL5880846 0.76 MAPT (0.46)
SCHEMBL5880719 0.76 KDM4E (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110070187-A1 Methods for the Preparation of HCV Polymerase Inhibitors PFIZER INC. 2011-03-24 US disclosed
US-7807838-B2 Methods for the preparation of HCV polymerase inhibitors PFIZER INC. (US) 2010-10-05 US disclosed
US-20090023921-A1 METHODS FOR THE PREPARATION OF HCV POLYMERASE INHIBITORS PFIZER INC 2009-01-22 US disclosed
EP-1928878-A1 METHODS FOR THE PREPARATION OF HCV POLYMERASE INHIBITORS PFIZER INC. (US) 2008-06-11 EP disclosed
WO-2007023381-A1 METHODS FOR THE PREPARATION OF HCV POLYMERASE INHIBITORS PFIZER INC. (US) 2007-03-01 WO disclosed